DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
compose your message
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
GBT Supports Sickle Cell Patients During COVID-19 Pandemic
Global Blood Therapeutics (GBT) is taking proactive measures to support public health efforts and sickle cell disease (SCD) patients during the global COVID-19 pandemic.
To help stem the spread of the coronavirus, the company is backing public health strategies, including social distancing. Specifically, GBT is temporarily prohibiting all field team in-person interactions, including visits to physicians, clinics, hospitals and payers.
GBT also seeks to assure SCD patients that GBT Source, the company’s support program for those prescribed Oxbryta, remains available to help with new enrollments and reimbursement, as well as financial, co-pay, treatment adherence, and refill support.
videos & visualsCOVID-19 & Sickle Cell Disorder (Sickle Cell Foundation Nigeria)https://www.youtube.com/watch?v=7HJGuphu...
education & researchFrequently Asked Questions About the COVID-19 VaccineWhy should I get vaccinated for COVID-19...
education & researchCoronavirus (COVID-19) & Sickle Cell DisorderCOVID-19 is a new illness that can affec...
news & eventsTrauma, Quarantine, and Isolation – WebinarThe Sickle Cell Mental Health Initiative...
news & eventsNORD/EURORDIS-Rare Diseases Europe Joint Statement on COVID-19 and Orphan Drug LegislationThe National Organization for Rare Disor...
Community CenterListening to Sickle Cell Patients is Crucial During a CrisisI recently was admitted to the hospital ...
news & eventsExpert Opinion Hydroxyurea Could Prevent Strokes for People With Sickle Cell Disease in Lieu of Transfusions During ...The COVID-19 pandemic threatens to cause...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.